Abstract
One of the problems in the assessment of syncope is that most clinical episodes are not witnessed. Therefore, features such as asystole during the attack must be assumed on the basis of indirect evidence such as its induction with provocative maneuvers. Head up tilt test (HUT) is the most widely used of such maneuvers, and most discussions on the management or significance of asystole during syncope are based on the development of asystole during HUT. Therefore, before addressing the particular issue of asystole in vasovagal syncope (VVS), a critical review of the reliability of HUT to draw conclusions about such a topic is justified.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Kenny RA, Ingram A, Bayliss J, Sutton R (1986) Head-up tilt: a useful test for investigating unexplained syncope. Lancet 1:1352–1354
Almquist A, Goldenberg IF, Milstein S et al (1989) Provocation of bradycardia and hypotension by isoproterenol and upright tilt test in patients with unexplained syncope. N Engl J Med 320: 346–351
Milstein S, Reyes WJ, Benditt DG (1989) Upright body tilt for evaluation of patients with recurrent, unexplained syncope. PACE 12: 117–124
Strasberg B, Rechavia E, Sagie A et al (1989) The head-up tilt test in patients with syncope of unknown origin. Am Heart J 118: 923–927
Fitzpatrick AP, Theodorakis G, Vardas P, Sutton R (1991) Methodology of head-up tilt testing in patients with unexplained syncope. J Am Coll Cardiol 17: 125–30
Sheldon R, Killam S (1992) Methodology of isoproterenol-tilt table testing in patients with syncope. J Am Coll Cardiol 19: 773–779
Shalev Y, Gal R, Tchou P et al (1991) Echocardiographic demonstration of decreased left ventricular dimensions and vigorous myocardial contraction during syncope induced by head-up tilt test. J Am Coll Cardiol 1991; 18: 746–751
Grubb BP, Gerard G, Temesy-Armos P, Roush K, Hanhn H, Elliot L (1991) Cerebral vasoconstriction during upright tilt induced syncope. PACE 1991; 14: 662 (abstr)
Fitzpatrick A, Williams T, Ahmed R, Lightman S, Bloom SR, Sutton R (1992) Echocardiographic and endocrine changes during vasovagal syncope induced by prolonged head-up tilt. Eur J Cardiac Pacing Electrophysiol 2: 121–128
Moya A, Permanyer-Miralda G, Sagrista J, Mont L, Rius T, Soler-Soler J (1993) Analisis de las respuestas a la prueba en tabla basculante en función de las características clínicas de los episodios sincopales en pacientes sin cardiopatia aparente. Rev Esp Cardiol 46: 214–219
Sutton R, Petersen M, Brignole M, Raviele A, Menozzi C, Giani P (1992) Proposed classification for tilt induced vaso-vagal syncope. Eur J Cardiac Pacing Electrophysiol 2: 12.180–183
Milstein S, Buetikofer J, Dunnigan A, Benditt DG, Gornik C, Reyes WJ (1990) Usefulness of disopyramide for prevention of upright tilt-induced hypotension-bradycardia. Am J Cardiol 65: 1339–13344
Raviele A, Gasparini G, Di Pede F, Delise P, Bonso A, Piccolo E (1990) Usefulness of head-up tilt-test in evaluating patients with syncope of unknown origin and negative electrophysiologic study. Am J Cardiol 65:1322–1327
Grubb BP, Wolfe DA, Samoil D, Temesy-Armos P, Hahn H, Elliott L (1993) Usefulness of fluoxetine for prevention of resistant upright tilt induced syncope. PACE 16: 458–464
Sra JS, Murthy VS, Jayazery M et al (1992) Use of intravenous esmolol to predict efficacy of oral beta-adrenergic blocker therapy in patients with neurocardiogenic syncope. J Am Coll Cardiol 402–408
Grubb BP, Temesy-Armos P, Hann H, Elliot L (1991) Utility of upright tilt-table testing in the evaluation and management of syncope of unknown origin. Am J Med 90: 6–10
Morillo CA, Leitch JW, Yee R, Klein GJ (1993) A placebo controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt. J Am Coll Cardiol 22: 1843–1848
Wolfe DA, Grubb BP, Temesy-Armos PN, Samoil D, Kosinski DJ, Brewster PS (1993) Usefulness of verapamil in preventing upright tilt induced (vasovagal-mediated) hypotension and bradycardia. J Am Coll Cardiol 21: 172A (abstr)
Natale A, Sra J, Dhala A et al (1993) Clinical follow-up in 327 patients with positive head-up tilt: how should appropriate therapy be chosen? Circulation 88: I-398 (abstr)
Fitzpatrick AP, Ahmed R, Williams S, Sutton R (1991) A randomised trial of medical therapy in “malignant vasovagal syndrome” or neurally-mediated bradycardia/hypotension syndrome“. Eur J Cardiac Pacing Electrophysiol 2: 99–102
Fitzpatrick AP, Travill CM, Vardas PE et al (1990) Recurrent symptoms after ventricular pacing in unexplained syncope. PACE 13: 619–624
Fitzpatrick A, Theodorakis G, Ahmed R, Williams T, Sutton R (1991) Dual chamber pacing aborts vasovagal syncope induced by head-up 600 tilt. PACE 13: 13–19
Grubb BP, Temesy-Armos P, Moore J, Wolfe D, Hahn H, Elliot L (1992) Head-upright tilt-table testing in evaluation and management of the malignant vasovagal syndrome. Am J Cardiol 69: 904–908
Sra JS, Jayazery MR, Avitalli B et al (1993) Comparison of cardiac pacing with drug therapy in the treatment of neurocardiogenic (vasovagal) syncope with bradycardia or asystole. N Engl J Med 328: 1085–1090
Samoil D, Grubb BP, Brewster P, Moore J, Temesy-Armos P (1993) Comparison of single and dual chamber pacing techniques in prevention of upright tilt induced vasovagal syncope. Eur J Cardiac Pacing Electrophysiol 3: 36–41
Moya A, Permanyer-Miralda G, Sagristà J, Mont L, Rius T, Soler-Soler J (1993) Response to dual chamber pacing in patients with syncope and positive tilt test with cardioinhibitory response. PACE 16: 936 (abstr)
Benditt DG, Petersen M, Lurie KG, Giubb BP, Sutton R (1995) Cardiac pacing for prevention of recurrent vasovagal syncope. Ann Intern Med 122: 204–209
Kramer MS (1988) Diagnostic tests. In: Kramer MS (ed) Clinical epidemiology and biostatistics. Springer, Berlin Heidelberg New York, pp 201–219
Brignole M, Menozzi C, Gianfranchi L, Oddine D, Lollis G, Berttulla A (1991) Neurally mediated syncope detected by carotid sinus massage and head-up tilt test in sick sinus syndrome. Am J Cardiol 68: 1032–1036
Kapoor WN, Brant N (1992) Evaluation of syncope by upright tilt testing with isoproterenol. A nonspecific test. Ann Intern Med 116: 356–363
Ambrosi P, Djiane P, Durand JM et al (1992) Intérêt et limites du test d’inclinaison dans le diagnostic étiologique des malaises brefs. Arch Mal Coeur 85: 345–350
Raviele A, Gasparini G, Di Pede F et al (1994) Nitroglycerin infusion during upright tilt: a new test for the diagnosis of vaso-vagal syncope. Am Heart J 127: 103–111
Kapoor WN (1990) Evaluation and outcome of patients with syncope. Medicine 69: 160–175
Kapoor WN, Smith MA, Miller NL (1994) Upright tilt testing in evaluating syncope. A comprehensive literature review. Am J Med 97: 78–88
Glick G, Yu PN (1963) Hemodynamic changes during spontaneous vasovagal reaction. Am J Med 34: 42–51
Abboud FM (1989) Ventricular syncope: is the heart a sensory organ? N Engl J Med 320: 390–392
Thames MD, Kopfenstein HS, Abboud FM, Marck AL, Walker JL (1978) Preferential distribution of inhibitory cardiac receptors with vagal afferents to the inferoposterior wall of left ventricle during coronary occlusion in the dog. Cire Res 43: 521–529
García Civera R, Ruíz Grandi R, Cosín Aguilar J, López Merino V (1989) Sfncope vasovagal. In: García Civera R, Sanjuan Maïíez R, Cosín Aguilar J, López Merino V (eds). Sfncope. MCR, Barcelona, pp 177–198
Moya A, Permanyer-Miralda G, Sagrista-Sauleda J et al (1995) Limitations of head-up tilt test for evaluating the efficacy of therapeutic interventions in patients with vasovagal syncope: results of a controlled study of etilefrine versus placebo. J Am Coll Cardiol 25: 65–69
Sra JS, Murthy VS, Jayazery MR et al (1992) Use of intravenous esmolol to predict efficacy of oral beta-adrenergic blocker therapy in patients with neurocardiogenic syncope. J Am Coll Cardiol. 19: 402–408
Fitzpatrick AP, Travill CM, Vardas PE et al (1991) A randomised trial of medical therapy in “malignant vasovagal syndrome” or neurally-mediated bradycardia/hypotension syndrome“. Eur J Cardiac Pacing Electrophysiol 2:99–102
Blanc JJ, Corber C, Mansourati J, Genet L (1991) Evaluation du traitment betabloquant dans les syncopes vasovagals reproduits par le test d’inclinaison. Arch Mal Coeur 84: 1453–1457
Brignole M, Menozzi C, Gianfranchi L, Lolli G, Bottoni N, Oddone D (1992) A controlled trial of acute and long-term medical therapy in tilt-induced neurally mediated syncope. Am J Cardiol 70: 339–342
Milstein S, Buetikofer J, Dunningan A, Benditt DG, Gornick C, Reyes WJ (1990) Usefulness of disopyramide for prevention of upright tilt-induced hypotension-bradycardia. Am J Cardiol 65: 1339–1344
López Candel J, Picó Aracil F, Sanchez Munoz JJ et al (1993) Sincope vasovagal maligno. Diagnostico’y ensayo terapéutico basado en el test del ortostatismo (test del tilt). Rev Esp Cardiol 46: 28–33
Grubb BP, Wolfe DA, Samoil D, Temesy-Armos P, Hahn H, Elliot L (1991) Usefulness of fluoxetine for prevention of resistant upright tilt induced syncope. PACE 90: 6–10
Brignole M, Menozzi C, Gianfranchi L, Bottoni N, Lolli G (1992) The clinical and prognosis significance of asystolie response during the head-up tilt test. Eur J Cardiac Pacing Electrophysiol 2: 109–113
Moya A, Permanyer-Miralda G, Sagrista J, Rius T, Mont L, Soler-Soler J (1993) Influencia del use del isoproterenol en la respuesta al exploración en tabla basculante en pacientes con sincope de causa desconocida. Rev Esp Cardiol 46 [Suppl 1]: 11 (abstr)
de Buitleir M, Grogan EW, Picone MF, Casteen JA (1993) Immediate reproducibility of the tilt table test in adults with unexplained syncope. Am J Cardiol 71: 304–307
Chen XC, Chen MY, Remole S et al (1992) Reproducibility of head up tilt-table testing for eliciting susceptibility to neurally mediated syncope in patients without structural heart disease. Am J Cardiol 69: 755–760
Brooks R, Ruskin JN, Powell AC, Newell J, Garan H, McGovern BA (1993) Prospective evaluation of day-to-day reproducibility of upright tilt-table testing in unexplained syncope. Am J Cardiol 71: 1289–1292
Grubb BP, Wolfe D, Temesy-Armos P, Hahn H, Elliot L (1992) Reproducibility of head-up tilt table test results in patients with syncope. PACE 15: 1477–1481
Sheldon R, Splawinski J, Killiam S (1992) Reproducibility of isoproterenol tilt-table tests in patients with syncope. Am J Cardiol 69: 1300–1305
Fish FA, Strasburger JF, Benson DW (1992) Reproducibility of a symptomatic response to upright tilt in young patients with unexplained syncope. Am J Cardiol 70: 605–609
Milstein S, Buetikofer J, Lesser J et al (1991) Cardiac asystole: a manifestation of neurally mediated hypotension-bradycardia. J Am Coll Cardiol 14: 1622–1632
Rius T, Moya A, Sagristâ J, Permanyer-Miralda G, Mont L, Soler-Soler J (1993) Valor de la prueba en tabla basculante en pacientes portadores de marcapasos VVI con sfncopes recidi-vantes. Rev Esp Cardiol 46 [Suppl I]: 11 (abastract)
Dangovian MI, Jarandilla R, Frumin H (1992) Prolonged asystole during head-up tilt table testing after beta-blockade. PACE 15: 14–16
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Italia, Milano
About this paper
Cite this paper
Moya, A., Permanyer-Miralda, G., Sagristá-Sauleda, J. (1996). Vasovagal Syncope with Asystolic Pause: Drugs, Pacemaker, or Both?. In: Raviele, A. (eds) Cardiac Arrhythmias 1995. Springer, Milano. https://doi.org/10.1007/978-88-470-2223-2_22
Download citation
DOI: https://doi.org/10.1007/978-88-470-2223-2_22
Publisher Name: Springer, Milano
Print ISBN: 978-3-540-75012-3
Online ISBN: 978-88-470-2223-2
eBook Packages: Springer Book Archive